Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|April 30, 2008
In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococciGregory T Robertson, Eric J Bonventre, Timothy B Doyle, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2008
In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureusGregory T Robertson, Eric J Bonventre, Timothy B Doyle, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2026
Pretomanid vs delamanid in a bedaquiline-linezolid regimen: efficacy in a high-burden tuberculosis mouse modelJason E Cummings, Lisa K Woolhiser, Vincent Guglielmi, et al.
Antimicrobial Agents and Chemotherapy|August 23, 2021
Model-Based Exposure-Response Assessment for Spectinamide 1810 in a Mouse Model of TuberculosisSantosh Wagh, Chetan Rathi, Pradeep B Lukka, et al.
Veterinary Microbiology|May 3, 2005
Role of HdeA in acid resistance and virulence in Brucella abortus 2308Michelle Wright Valderas, Rosemarie B Alcantara, John E Baumgartner, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2006
New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferasesKeith D Combrink, Daniel A Denton, Susan Harran, et al.
Pageof 8